Presentation on theme: "Drug Treatment Monitoring Unit"— Presentation transcript:
1 Drug Treatment Monitoring Unit NDTMS Core Dataset G Training for Treatment Providers and CommissionersDrug Treatment Monitoring UnitMarch 2010
2 Ground RulesPlease respect those around you by not holding individual conversations whilst the sessions are in progressPlease put mobiles on silent/vibratePlease take any calls outside of the meeting
3 Aims Clarify the changes in Core Data Set ‘G’ Clarify consent and confidentialityReview Data Quality and TOP complianceProvide information around current reporting and monitoringClarify numbers in effective treatment, successful completions and waiting times calculationsApril 6, 2017
4 Essential Elements of Treatment Provision The needs of all drug misusers should be assessed across the four domains of drug and alcohol misuse health social functioning and criminal involvement.All drug misusers entering structured drug treatment should have a care or treatment plan which is regularly reviewed.A named individual should manage and deliver aspects of the patient’s care or treatment plan.(Source: Drug Misuse and Dependence: UK guidelines on clinical management‚ 2007)NDTMS collects information all four domainsApril 6, 2017
5 Why is information needed for NDTMS? The drug and alcohol treatment information that you provide to the NDTMS is used for several purposes. Primarily used for:Assess the number of individuals attending drug and alcohol services in order to monitor the progress of the national drug and alcohol strategies;Evaluate the efficiency and effectiveness of drug and alcohol treatment provision‚ including treatment outcomes for clients.Monitor the use of resources. This helps ensure equitable funding of drug and alcohol services nationally.Provide a local and regional picture of drug and alcohol clients and their needs‚ which will assist service commissioners such as DAATs‚ PCTs and local authorities in planning and developing better drug and alcohol treatment services that are more appropriate to their geographical area.Produce statistics and to support research on drug and alcohol use‚ treatment or general public.April 6, 2017
6 DAAT Profile: 2008-09 http://www.dtmu.org.uk/DAT Profiles 2008-09.html The DTMU DAAT Profiles for Adults and YP for 2008/09 were released in February Electronic copies of these reports can be found onApril 6, 2017
7 Changes with Core Data Set G One new data itemModalities updated in line with Orange Book clinical guidanceReference data items updated in line with NHS data dictionaryYP outcomes updatedApril 6, 2017
8 New data item: Local agency details Field to be reviewed by regional team Collected at Modality start Intended to be used to report prescribing on behalf of another agency Possible values: GP, Pharmacist, NDTMS agency code, GP practice codeApril 6, 2017
9 CDS ‘G’ Treatment Interventions Updated options April 6, 2017
10 Updated treatment interventions Modalities updated in line with Orange Book clinical guidance“The SCAN consensus document on inpatient treatment (SCAN, 2006) defined the core work of an inpatient unit as comprising assessment, stabilisation and detoxification (or assisted withdrawal). Although these may be combined during a patient’s stay, the patient’s plan of care should usually identify one task as the principal purpose of administration”Proposals to modify the codes used to record the types of drug treatment being provided on the National Drug Treatment Monitoring System – July 2009April 6, 2017
11 Tier 2 Adult Drug Modalities OutreachAdvice and InformationNeedle ExchangeAftercareClients receiving these Tier 2 interventions will NOT count for performance targets1. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.
12 Tier 3 Adult Drug Modalities Specialist PrescribingGP PrescribingBehavioural Couples TherapyFamily TherapyContingency Management (drug specific)Psychosocial Intervention to address common mental disordersOther Formal Psychosocial TherapyStructured Day ProgrammeOther Structured InterventionClients receiving these Tier 3 interventions will count for performance targets1. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.
13 Psychosocial interventions Behavioural couples therapyFamily therapyContingency management (drug specific)Psychosocial interventions to address common mental disordersOther formal psychosocial therapy (e.g. community reinforcement approach or social behaviour network therapy)Structured psychosocial interventions have been expanded:81 – Behavioural couples therapy82 – Family therapy83 – Contingency management (drug specific)84 – Psychosocial interventions to address common mental disorders85 – Other formal psychosocial therapyApril 6, 2017
14 Behavioural couples therapy Behavioural couples therapy is a specific psychosocial intervention that should only be available for use with clients who have an established relationship and a drug-free partner willing to engage in treatment.The focus is on the client’s drug use and should consist of at least twelve weekly sessions.Structured psychosocial interventions have been expanded:81 – Behavioural couples therapy82 – Family therapy83 – Contingency management (drug specific)84 – Psychosocial interventions to address common mental disorders85 – Other formal psychosocial therapyApril 6, 2017
15 Family therapyFamily therapy is a structured psychosocial intervention that is delivered by a competent clinician. The focus is on discussion with families relating to the sources of stress associated with drug misuse and aims to support and promote the family in developing more effective coping behaviours. Family therapy should only be recorded under this code when the client is actively involved in the intervention. This does not reflect family work that is done where the service user is not engaged in the intervention.Structured psychosocial interventions have been expanded:81 – Behavioural couples therapy82 – Family therapy83 – Contingency management (drug specific)84 – Psychosocial interventions to address common mental disorders85 – Other formal psychosocial therapyApril 6, 2017
16 Contingency management (drug specific) Structured behavioural programmes using incentives to reinforce changes in behaviour. Behaviour changes incentivised for people receiving methadone maintenance treatment include reduced illicit drug use and/or increased engagement with services. Behaviour changes incentivised for people who primarily misuse stimulants include reduced illicit drug use, abstinence and/or increased engagement with services.Structured psychosocial interventions have been expanded:81 – Behavioural couples therapy82 – Family therapy83 – Contingency management (drug specific)84 – Psychosocial interventions to address common mental disorders85 – Other formal psychosocial therapyApril 6, 2017
17 Psychosocial interventions to address common mental disorders Many drug users also have considerable co-morbid problems, particularly common mental health problems such as anxiety and depression.There is evidence that a range of evidence-based psychosocial interventions can be beneficial for a wide range of mental disorders.Such disorders may include: depression (NICE, 2007b); anxiety (NICE, 2007c); post traumatic stress disorder (NICE, 2005a); eating disorders (NICE, 2004); obsessive compulsive disorder (NICE, 2005b); antenatal and postnatal mental health (NICE, 2007d)Psychosocial interventions to address these disorders range from, for example, guided self help and brief interventions for mild forms of problems to cognitive behavioural therapy and social support for more moderate forms.All psychosocial intervention to address common mental disorders should be recorded using this code regardless of their intensity.Structured psychosocial interventions have been expanded:81 – Behavioural couples therapy82 – Family therapy83 – Contingency management (drug specific)84 – Psychosocial interventions to address common mental disorders85 – Other formal psychosocial therapyApril 6, 2017
18 Other formal psychosocial therapy (e.g. community reinforcement approach or social behaviour network therapy) This includes other psychosocial therapies that are used in drug treatment and beneficial for some clients as they are practical and broad-based techniques. Psychosocial therapies recorded under this category will include the Community Reinforcement Approach and Social Behaviour Network Therapy.Structured psychosocial interventions have been expanded:81 – Behavioural couples therapy82 – Family therapy83 – Contingency management (drug specific)84 – Psychosocial interventions to address common mental disorders85 – Other formal psychosocial therapyApril 6, 2017
19 Tier 4 Adult Drug Modalities Inpatient Treatment Assessment OnlyInpatient Treatment StabilisationInpatient Treatment Detoxification (assisted withdrawal)Residential RehabilitationClients receiving these Tier 4 interventions will count for performance targets1. ‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.
21 Inpatient treatment Assessment Only Individuals with drug and alcohol dependence present with a wide range of psychiatric, physical and social problems.Substance misuse services provide a comprehensive assessment of these needs and formulate a treatment care plan to tackle them.A hospital setting permits a higher level of medical observation, supervision and safety for service users needing more intensive forms of care. Specific tasks of the IPU may include:• Assessment of substance use• Assessment of mental health• Assessment of physical health• Assessment of social problemsThese should be undertaken as described in the Inpatient Treatment of Drug and Alcohol Misusers in the National Health Service – Scan consensus project (2006).This document is available at using the following link.April 6, 2017
22 Inpatient treatment Stabilisation There is considerable evidence that the number of service users with more complex problems (coexisting physical and mental illness, dependence on more than one substance) is increasing. Such cases can be managed in a community setting, but the IPU setting permits a high level of medical observation, supervision and safety for service users needing more intensive forms of care. The IPU should have care pathways, clinical protocols, and sufficient human and physical resources to offer the following range of stabilisation procedures: 1. Dose titration 2. Dose titration on injectable opioid medication 3. Stabilisation on maintenance therapy 4. Combination assisted withdrawal/stabilisationApril 6, 2017
23 Inpatient treatment Detoxification Assisted withdrawal should only be encouraged as the first step in a longer treatment process, and needs to be integrated with relapse prevention or rehabilitation treatment programmes which can be provided in the NHS or independent/non-statutory sector. Withdrawal in an IPU setting offers better opportunities for clinicians to ensure compliance with medication and to manage complications. IPU admission also offers a major opportunity to recruit service users into longer-term treatment to reduce the risk of relapse back into regular drug or alcohol use. The IPU should have care pathways, clinical protocols, and sufficient human and physical resources to offer assisted withdrawal for a wide range of single and poly- drug and alcohol misuse problems.April 6, 2017
24 Adult Alcohol Modalities Tier 3ALC - Community PrescribingALC - Structured Psychosocial InterventionALC - Structured Day ProgrammeALC - Other Structured TreatmentTier 4ALC - Inpatient TreatmentALC - Residential RehabilitationTier 2ALC – Brief InterventionsWill NOT count towards numbers in Treatment.‘Other Structured Intervention’ – must be care planned for it to be classed as tier 3 activity.
25 Young People Modalities Tier 3YP Psychosocial InterventionYP Harm Reduction ServicesYP Family WorkYP Specialist Pharmacological InterventionsTier 4YP Access to residential treatment for substance misuseTier 2YP Non-structured interventionYoung People receiving these Tier 3/4 interventions will count towards performance targetsVery clear that Psychosocial Interventions can include both one-to-one and group work – it is the care planned element that is key to whether or not it is considered to be T2/31. Will the tier 2 YP modalities still be available from 1st April 2007 (should these be removed from the slide?)
26 Question: Are you all reporting treatment modalities against individual clients episode of treatment?April 6, 2017
27 CDS ‘G’ Reference Data Changes to reference values in line with NHS Data Dictionary 27
28 Employment statusRegular Employment Pupil/Student Long term sick or disabled Homemaker Retired from workUnemployed and seeking workNot receiving benefitsUnpaid voluntary workRetired from paid workNot statedOtherNot known‘Long term sick or disabled’, ‘Homemaker’ and ‘Retired from work’ have all been included following expansion of previous ‘Economically inactive’ option.‘Unemployed and seeking work’, ‘Not receiving benefits’, ‘Unpaid voluntary work’, ‘Retired from paid work’ and ‘Not stated’ have been included following expansion of previous ‘Unemployed’ option.April 6, 2017
29 Sexuality Gay: renamed to Homosexual Not Disclosed: renamed to Not RecordedApril 6, 2017
30 Consent Yes the person consented No the person has not consented April 6, 2017
31 Previously Hep B Infected Yes has had a previous Hepatitis B infection diagnosed;No has never had a previous Hepatitis B infection diagnosed;Not KnownApril 6, 2017
32 Hepatitis C Positive Yes is Hepatitis C Positive No is not Hepatitis C PositiveNot KnownApril 6, 2017
33 Injecting Status Previously Injected (but not currently) Currently InjectingNever InjectedClient Declined to AnswerApril 6, 2017
34 Referral Sources (Drug & Alcohol) Arrest Referral / DIP is now:Arrest ReferralDIPCustody Service has been removedApril 6, 2017
36 Drug Codes Methylone Mephedrone No Second Drug No Third Drug April 6, 2017
37 CDS ‘G’ Young People Changes to YP Outcomes April 6, 2017
38 Changes to YP outcomes There are some changes to the YP outcomes. These apply to all young people seen at a Young People’s treatment provider and should only be completed by these agencies.YP outcomes have been collected since April 2009.YP NDTMS Event: 31st March‚ YMCA GuildfordApril 6, 2017
40 Information Management Clinicians need to:Keep patient records;Ensure appropriate information sharing‚ confidentiality and data protection;Collect and analyse data; andMake effective use of information and data;(Drug Misuse and Dependence: UK guidelines on clinical management‚ 2007)If a client refuses consent – NDTMS and TOP should still be completed within your own system, consent flagged as no, and we will receive only minimal non-identifiable data.If the client is not aware that the DAAT would have sight of the attributable data, their row level data cannot be shared with the DAATs.
41 Information Sharing“Information sharing can be of great value to the direct care of individual patients and may also contribute indirectly to the delivery and effectiveness of the drug treatment system. Information sharing protocols should be consistent with guidance from local Caldicott Guardian and any national guidance‚ and acknowledge that patient consent to disclosure is key in most situations where identifiable information is shared.”(Drug Misuse and Dependence: UK guidelines on clinical management‚ 2007)If a client refuses consent – NDTMS and TOP should still be completed within your own system, consent flagged as no, and we will receive only minimal non-identifiable data.If the client is not aware that the DAAT would have sight of the attributable data, their row level data cannot be shared with the DAATs.
42 Data Sharing Protocols Having data sharing protocols in place‚ that outline how and why data is shared within and between organisations‚ is good practice.Scenarios:DAT Wide Systems: this will necessitate information sharing across treatment services and/or Drug and Alcohol Action Teams;Multi-site service provider software (e.g. Addaction use one system nationally):Multiple service providers delivering simultaneous treatment to a client‚ irrespective of the software used. This is relevant to TOP data where a service provider should‚ subject to permissions and data sharing protocols‚ send copies of the TOP information to other agencies.Part of the assessment process should be establishing with a client how information relating to them may be shared and for what purpose. This may be done as part of the care planning process and should have started at the time of assessment.
43 ConsentClients should give written consent to share information about their care plan. This consent should specifically state which agencies the client consents to have information received about them and which they do not. A form recording the client’s consent should be kept in the notes. Consent should be reviewed at the time of reviewing the care plan.If a client refuses consent – NDTMS and TOP should still be completed within your own system, consent flagged as no, and we will receive only minimal non-identifiable data.If the client is not aware that the DAAT would have sight of the attributable data, their row level data cannot be shared with the DAATs.
44 NTA Confidentiality Toolkit Confidentiality policy should be clearly explained to client (verbally and written form), before assessment for treatment.Should cover:What information will be collected by the agencyWhen and what information will be shared with other services and organisationsWho information will go to and why (NDTMS)When the confidentiality may be breached(NTA Confidentiality Toolkit, 2009 NTA)
46 Discharge Data Discharge Date Discharge Reason If a Discharge Date is entered, then a Discharge Reason must be given and vice versa.Discharge information must be reported accurately and in a timely fashion as it is used to calculate In treatment Rates.Modality End Date (s) must be populated for discharged clients.If agencies want other discharge reasons added, we can put them forward to the NTA on their behalf. Can’t guarantee that it will be added, but we can try.
47 Drug Discharge Reasons Successful CompletionsTreatment completed - drug freeTreatment completed - occasional user (not opiates or crack)
48 Drug Discharge Reasons TransfersTransferred – not in custodyTransferred – in custody
49 Drug Discharge Reasons IncompleteIncomplete – Dropped OutIncomplete – Treatment withdrawn by providerIncomplete – Retained in CustodyIncomplete – Treatment Commencement Declined by ClientIncomplete – Client Died
50 Planned Discharge Project The DTMU are currently providing support to a national exercise around Planned and Unplanned Discharges being undertaken by the Regional NTA Teams. The number of unplanned discharges is rising, a trend which the NTA is keen to address immediately. In order to enable the agencies to investigate individual unplanned discharges, the DTMU have made available a spreadsheet which contains the attributable level data for unplanned discharges only for your service, thus the total number of discharges will be less than the summary sheet, which includes planned discharge reasons. "The DTMU are currently providing support to a national exercise around Planned and Unplanned Discharges being undertaken by the Regional NTA Teams. The number of unplanned discharges is rising, a trend which the NTA is keen to address immediately. As such, they have provided information at a Partnership and Agency level about where clients are exiting the treatment system and what the corresponding discharge reasons are. In order to enable the agencies to investigate individual unplanned discharges, the DTMU have made available a spreadsheet which contains the attributable level data for unplanned discharges only for your service, thus the total number of discharges will be less than the summary sheet, which includes planned discharge reasons. This is available on the SE Region Dropbox, which I have set you up with access. We have notified the DAAT that we have shared this information with you.This data is to provide you with information around the clients who have left the treatment system in an unplanned way and this exit took place at your agency. In order to try and improve client engagement with the treatment system and consequently the numbers of planned discharges from the treatment system, the following considerations should be made:- Referred on (where CDS-E has been reported in this financial year) or Transferred - not in custodyThis indicates that a client has been referred to another agency, and has not engaged in treatment. In order to minimise drop-out at this point, it's important to consider your own agency processes around supporting that client until they have engaged in treatment at the new service. What steps are taken to ensure that they arrive? Is adequate information shared with the next agency to ensure that the client information is recorded consistently between the two agencies (initials/DOB)? What happens if they don't turn up to the appointment? How is this followed up? What steps are taken to reengage that client with your own agency? Are you using this to refer to Tier 2? If so, why? Tier 2 do not report to NDTMS, so the client will not appear at another agency and so be deemed as lost to the system. Where this is aftercare, should a treatment completed reason have been more appropriately used at your agency to discharge the client? Or, were they being referred back to Tier 2 to try and keep them engaged in the system?Answers to these questions should help you to understand where you can effectively focus your efforts to minimise drop-out from the structured treatment pathway.- Treatment Incomplete - Dropped out/LeftWhat steps were taken to reengage the client? Were they followed up? Could anything more have been done? Could they have been referred to another structured treatment agency for more appropriate interventions? At what stage in their treatment journey were they - did they simply miss the final wrap-up meeting?Focusing efforts on these two areas should enable you to understand the reasons behind the levels of unplanned discharges in your agency and inform decisions around implementing improvements in processes that can support re-engaging or maintaining client engagement in the treatment system.If you have any queries, please contact us or the NTA Regional Deputy Manager for your partnership area."
55 What is the TOP? Treatment Outcomes Profile • An instrument to measure treatment outcomes• A simple, short set of questions• To plot clients’ progress through structured treatment - a measure of how well clients do in treatment• Reported to NDTMS55
56 All clinicians using the TOP should know the following 5 key messages TOP: Key factsClinical usefulnessValidationAll clinicians using the TOP should know the following 5 key messages
57 How is TOP useful clinically? The TOP is a clinically useful tool for monitoring progress and identifying change during treatmentTOP: Key factsClinical usefulnessValidationHow is TOP useful clinically?A means of identifying and understanding change for an individual client (comparing TOP scores)Allows the keyworker to feedback the progress a client has made. The client can see these changes visually (using TOP Progress Tracker). Visual feedback may be more effective than verbal feedback aloneAssistance given in the care planning process; highlighting areas of difficulty that may need addressing to increase the potential treatment gainsHelps summarise the clients current situation and stimulates discussions in clinical meetings and supervisionProvides the keyworker with an additional source of information/evidence that could be used when discussing a specific care plan
58 How to complete the Treatment Outcomes Profile (TOP) TOP: Key factsClinical usefulnessValidationClient identifiers required to prevent double counting in the NDTMSRecord the number of days in which the client has used each drug. A number should always be used (0-28) except when a client declines to answer which should be recorded as ‘NA’Record the number of days that the client has injected. If the client does not inject record ‘0’. Do NOT use ‘NA’. Also record whether the client has shared by marking the box with a ‘Y’ or ‘N’Some clients commit crime in order to fund their drug use. An obvious treatment goal is to reduce this activity. Record the number of days (0-28) for section 3a & b and ‘Y’ or ‘N’ if the client has committed crimes (c,d,e,f) in the last 28 daysCircle the rating scales for Psychological, Physical & Quality of Life in accordance to where the client indicates.Record the number of days paid work and college between (0-28) and only use ‘NA’ if the client declines to answer
59 Three types of questions Yes and no a simple tick for yes or noTimeline the client recalls the number of days in each of the past four weeks on which they did something, e.g. the number of days they used heroinRating scale a 20-point scale from poor to good. Together with the client, mark the scale in an appropriate place59
60 Completion and non-responses Ask every question, complete every blue boxEnter "NA" in the blue box:if client refuses to answer a questionor if, even after prompting, client cannot recall60
61 TOP NDTMS Data You should aim to ask and complete every question. Do not leave any of the blue boxes blankEnter “NA” if a client refuses to answer a question or cannot recall.Where DAAT areas have incorporated the form into their own paperwork, the questions should be replicated exactly as they appear on the TOP form and need to be input into the NDTMS at the appropriate points in the client treatment. The above points apply to locally adapted paperwork as well.61
62 When should the TOP be completed? At start of new treatment journeyto capture pre-treatment snapshot of client behaviour and situationAnd then every three monthsusually as part of a care plan review - to compare with pre-treatment snapshot and previous quarterly TOP results(Also on existing clients every three months)At Treatment Exit62
63 Further Information & clinical tools This is a very brief introduction to the TOP: more information is available atTOP: Key factsClinical usefulnessValidationThis section is a very brief introduction to the TOP and covers only the very basic information that is required to start using the TOP with clientsFurther Information & clinical toolsGuidanceTOP reporting protocol: A keyworkers guideTOP completing TOP as a clinical interviewTOP Progress Tracker guide (DET)TOP Service user guideNDTMS practice guideTOP Managers guideClinical ToolsTOP formTOP form (low ink version)TOP Progress trackerCalendarTOP training packAll the above information is available at or complete the online order form at Alternatively, or telephone and quote product code
64 Discharge Data and TOP Complete TOP at discharge from treatment system This should be done face-to-face between keyworker and client where possibleMay be done over telephone where no other option available (i.e. in unplanned discharges)NOT acceptable to complete on clients’ behalf without client present64
65 When should the TOP be completed? Post dischargeif feasible or desirable for servicewon’t be performance managed by NTA65
66 TOP and Confidentiality TOP data submitted via NDTMS will have the same safeguards in relation to confidentiality as any other NDTMS dataThis should be carefully explained to the client and local confidentiality agreements should be modified as appropriate to take into account the introduction of TOP into clinical and reporting systems66
67 The benefits of the TOP continue to be recognised in clinical settings with its application in the UK and abroad having increasedTOP: Key factsClinical usefulnessValidationOver the last 12 months the NTA has received several requests from European and International colleagues to use the TOP to measure outcomes in their clinics and countries.Requests received fromIt’s recognised that the TOP benefits from beingWalesScotlandNorthern IrelandItalyTaiwanIranAustraliaChileRussiaFinlandCanadaMaltaSpainNew Zealandvalidated toolshort & easy to completeWhy?clinically useful toolcaptures a wide range of substancesbroadly covers all other relevant treatment domains
68 See the NTA website www. nta. nhs. org See the NTA website for more information on the use of TOP internationallyTOP: Key factsClinical usefulnessValidation
69 TOP ExceptionsLet’s review the January TOP Exceptions that were released on DAMS on 5th March 2010.What action needs to be taken forward?Please refer to January TOP Exceptions that were published on DAMS on 05/03/2010.April 6, 2017
75 Objectives Focus on Data Quality Data Completeness NDTMS Year End Review ( )Regional Data Quality InitiativesHow to address monthly data quality reports
76 Improving Service Provision “Drug treatment services are managed using close to “real-time” data provided from the NDTMS and client satisfaction and client outcome data”(Models of Care: Update 2005, Consultation)
77 DTMU Data Quality Strategy As part of SLA with NTA‚ an annual data quality strategy has to be produced and signed off by regional and central NTA.Covers the entire NDTMS dataset.Sets the data quality targets‚ which are based upon NTA HQ Monthly DQ Metrics.April 6, 2017
78 NTA Data Completeness Drivers NTA National RequirementsPercentage completion rate for Parental StatusPercentage completion rate for Children Living WithHidden HarmPSA 14 – To prevent substance misuse amongst young people helping to reduce links with crime, disorder, truancy, school failure, physical and mental health problems.Hep B Vaccination Status responses versus Hep B Intervention status responsesRoute of Administration Inject versus Injecting StatusHealth Interventions/BBVPSA 18 – To promote better health and wellbeing of all citizens of society.Completion of Modality StartPSA 25 – to deliver a sustained 1% per annum increase (of people held in effective treatment) on baseline duringCompletion of Accommodation Need & Employment StatusPSA 16 – to increase the proportion of socially of socially excluded adults in settled accommodation, employment education and trainings.78
79 DTMU Data Completeness Analysis DTMU release quarterly data completeness reports by partnership and by agency.Analysis is based on new presentations only.Quarterly /10 to be released in March.79
80 Q2 Data Completeness Analysis Let’s review the Q2 completeness that was released in early February.What action needs to be taken forward?80
81 What data quality issues are you facing? April 6, 2017
82 How can you improve your agency’s overall data quality and data completeness?
83 DTMU AnswersBefore submitting the monthly data submission check to see if all errors/warnings that could have occurred‚ have been addressed;Where amendments to client details have been made on your database‚ it is very important to notify Sue Dales to ensure that these changes are replicated on the regional NDTMS database.Ensure that all the fields that can be completed‚ are completed.April 6, 2017
84 DTMU Data Quality Standards All monthly agency submissions must contain at least 100% valid records.All monthly agency submissions must reach 99.5% data qualityAll fields of CDS-F populated, if appropriate.Files must be in a CSV format.All agencies must submit via the Upload Portal: https://www.ndtms.org/dams/
85 ANY QUESTIONS Regina.Lally@SPH.nhs.uk Sue.Dales@SPH.nhs.uk
86 Dami. Omole@sph. nhs. uk. Michael. Wallington@sph. nhs. uk Regina